Nozomi Ito
National Defense Medical College
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Nozomi Ito.
International Journal of Surgery Case Reports | 2016
Manabu Harada; Hironori Tsujimoto; Ken Nagata; Nozomi Ito; Kenji Yamazaki; Kyohei Kanematsu; Hiroyuki Horiguchi; Yoshiki Kajiwara; Shuichi Hiraki; Suefumi Aosasa; Junji Yamamoto; Kazuo Hase
Highlights • Bochdalek hernia is a congenital diaphragmatic hernia.• An incarcerated Bochdalek hernias is an uncommon in an adult.• Laparoscopic repair of an incarcerated Bochdalek hernia is safe and feasible.
International Journal of Surgery Case Reports | 2015
Yusuke Ishibashi; Hironori Tsujimoto; Keita Kouzu; Hiroyuki Horiguchi; Shinsuke Nomura; Nozomi Ito; Kyohei Kanematsu; Kenji Yamazaki; Shuichi Hiraki; Suefumi Aosasa; Takuji Noro; Junji Yamamoto; Kazuo Hase
Highlights • We present a rare case of huge retroperitoneal cystic lymphangioma, diagnosed radiologically.• The lymphangioma was successfully resected laparoscopically after aspiration using a SAND balloon catheter.• Our case demonstrates the feasibility of minimally invasive laparoscopic resection of such lesions.
Cancer Science | 2017
Naoko Sakamoto; Hironori Tsujimoto; Risa Takahata; Cao Brian; Zhao Ping; Nozomi Ito; Hideyuki Shimazaki; Takashi Ichikura; Kazuo Hase; George F. Vande Woude; Nariyoshi Shinomiya
The role of HGF/SF‐MET signaling is important in cancer progression, but its relation with Helicobacter pylori‐positive gastric cancers remains to be elucidated. In total, 201 patients with primary gastric carcinoma who underwent curative or debulking resection without preoperative chemotherapy were studied. MET4 and anti‐HGF/SF mAbs were used for immunohistochemical analysis. Survival of gastric cancer patients was estimated by Kaplan–Meier method and compared with log‐rank. Cox proportional hazards models were fit to determine the independent association of MET‐staining status with outcome. The effect of live H. pylori bacteria on cell signaling and biological behaviors was evaluated using gastric cancer cell lines. MET4‐positive gastric cancers showed poorer prognosis than MET4‐negative cases (overall survival, P = 0.02; relapse‐free survival, P = 0.06). Positive staining for MET4 was also a statistically significant factor to predict poor prognosis in H. pylori‐positive cases (overall survival, P < 0.01; relapse‐free survival, P = 0.01) but not in H. pylori‐negative cases. Gastric cancers positively stained with both HGF/SF and MET4 showed a tendency of the worst prognosis. Stimulation of MET‐positive gastric cancer cells with live H. pylori bacteria directly upregulated MET phosphorylation and activated MET downstream signals such as p44/42MAPK and Akt, conferring cell proliferation and anti‐apoptotic activity. In conclusion, positive staining for MET4 was useful for predicting poor prognosis of gastric cancers with H. pylori infection. Helicobacter pylori stimulated MET‐positive gastric cancers and activated downstream signaling, thereby promoting cancer proliferation and anti‐apoptotic activity. These results support the importance of H. pylori elimination from gastric epithelial surface in clinical therapy.
Annals of Surgical Oncology | 2018
Yusuke Ishibashi; Hironori Tsujimoto; Shuichi Hiraki; Isao Kumano; Yoshihisa Yaguchi; Hiroyuki Horiguchi; Shinsuke Nomura; Nozomi Ito; Eiji Shinto; Suefumi Aosasa; Junji Yamamoto; Hideki Ueno
BackgroundIt is reported that several systemic immunoinflammatory measures, including systemic immune-inflammatory index (SII), neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio, and C-reactive protein (CRP)-to-albumin ratio (CAR), are associated with survival in patients with various types of cancer.ObjectiveThe aim of the present study was to clear which systemic immunoinflammatory measures had the greatest prognostic values. In addition, we examined which component had the greatest prognostic power in patients with esophageal cancer.MethodsPreoperative systemic immunoinflammatory measures were evaluated in 143 patients undergoing esophageal resection for esophageal cancer from 2009 to 2014. Univariate and multivariate analyses were performed to determine the prognostic significance of these markers. Receiver operating characteristic (ROC) curves were plotted, and the area under the ROC curves (AUROCs) were compared to verify the accuracy of each measure in predicting overall survival (OS).ResultsIn univariate analysis, preoperative SII, NLR, and CAR were the predictors of OS in patients who underwent esophagectomy for esophageal cancer (p < 0.05, respectively), whereas in multivariate analysis, CAR and pathological tumor depth were the significant predictors of OS (hazard ratio [HR] 1.994, p = 0.03 vs. HR 1.967, p = 0.02, respectively). According to AUROC, the CRP (0.66) and albumin levels (0.66) were more important systemic immunoinflammatory measures than neutrophil (0.58), lymphocyte (0.63), and platelet (0.56) levels.ConclusionAmong systemic immunoinflammatory measures, CAR was the most significant predictor of OS in patients with esophageal cancer. CRP and albumin levels were more important components of systemic immunoinflammatory measures.
World Journal of Gastrointestinal Surgery | 2016
Yujiro Itazaki; Hironori Tsujimoto; Nozomi Ito; Hiroyuki Horiguchi; Shinsuke Nomura; Kyohei Kanematsu; Shuichi Hiraki; Suefumi Aosasa; Junji Yamamoto; Kazuo Hase
Pneumatosis intestinalis (PI) often represents a benign condition that should not be considered as an argument for surgery. We report a patient with PI and obstructing intussusception who underwent urgent colectomy and review the literatures regarding PI with intussusception. A 20-year-old man presented at our hospital with a 3-d intermittent lower abdominal pain history. He underwent steroid therapy for membranoproliferative glomerulonephritis for 4 years. Computed tomography revealed ascending colon intussusception with air within the wall. Intraoperative colonoscopy revealed numerous soft polypoid masses with normal overlying mucosa and right hemicolectomy was performed. Histological examination of colonic wall sections revealed large cysts in the submucosal layer. The pathological diagnosis was PI. Nine cases of intussusception associated with primary PI have been reported. Although primary PI often represents a benign condition that should not be considered as an argument for surgery, if the case involves intussusception and obstruction, emergent laparotomy should be considered.
Annals of medicine and surgery | 2016
Kyohei Kanematsu; Hironori Tsujimoto; Shinsuke Nomura; Hiroyuki Horiguchi; Nozomi Ito; Kenji Yamazaki; Shuichi Hiraki; Suefumi Aosasa; Junji Yamamoto; Kazuo Hase
A 57-year-old woman was admitted to National Defense Medical College hospital for treatment of gastric cancer with pyloric stenosis. She had been diagnosed with chronic kidney disease (CKD) 10 years prior, but received no hemodialysis. Because of peritoneal dissemination, a palliative distal gastrectomy was performed. In consideration of renal dysfunction, we decided for chemotherapy with paclitaxel, but not S-1 plus cisplatin regimen which is renal toxic agents. On the 29th postoperative day, chemotherapy using paclitaxel was initiated at a dose of 80 mg/m2. Paclitaxel was administered weekly on days 1, 8, and 15 on a 28-day cycle. The patient tolerated 13 courses of this treatment without any severe adverse effect, such as exacerbation of renal function. Despite the gradual increase in the level of tumor markers, metastases were not detected via radiography during the clinical course. Moreover, renal function was maintained for the duration of the clinical course. To date, standard chemotherapeutic treatment for patients with CKD has not been established. We conclude that weekly paclitaxel is a suitable treatment regimen for patients with renal failure requiring chemotherapy for advanced gastric cancer.
Molecular and Clinical Oncology | 2015
Hironori Tsujimoto; Shuichi Hiraki; Risa Takahata; Shinsuke Nomura; Nozomi Ito; Kyohei Kanematsu; Hiroyuki Horiguchi; Suefumi Aosasa; Junji Yamamoto; Kazuo Hase
Gastric Cancer | 2016
Hironori Tsujimoto; Hitoshi Tsuda; Shuichi Hiraki; Shinsuke Nomura; Nozomi Ito; Kyohei Kanematsu; Hiroyuki Horiguchi; Suefumi Aosasa; Junji Yamamoto; Kazuo Hase
Medicine | 2018
Ken Nagata; Hironori Tsujimoto; Hiromi Nagata; Manabu Harada; Nozomi Ito; Kyohei Kanematsu; Shinsuke Nomura; Hiroyuki Horiguchi; Shuichi Hiraki; Kazuo Hase; Junji Yamamoto; Hideki Ueno
Molecular and Clinical Oncology | 2016
Keita Kouzu; Hironori Tsujimoto; Shuichi Hiraki; Hiroyuki Horiguchi; Shinsuke Nomura; Nozomi Ito; Kyohei Kanematsu; Kenji Yamazaki; Suefumi Aosasa; Junji Yamamoto; Kazuo Hase